Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

(2009) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE

Src kinases as therapeutic targets for cancer

(2009) Lori C. Kim et al.   Nature Reviews Clinical Oncology

Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells

(2008) A. Esparis-Ogando et al.   ANNALS OF ONCOLOGY

Targeting Src in breast cancer

(2008) R. S. Finn   ANNALS OF ONCOLOGY

Validation of biomarkers for the study of environmental carcinogens: a review

(2008) Valentina Gallo et al.   BIOMARKERS

Erlotinib Attenuates Homologous Recombinational Repair of Chromosomal Breaks in Human Breast Cancer Cells

(2008) L. Li et al.   CANCER RESEARCH

Coupling of Mutated Met Variants to DNA Repair via Abl and Rad51

(2008) S. S. Ganapathipillai et al.   CANCER RESEARCH

Identifying Breast Cancer Druggable Oncogenic Alterations: Lessons Learned and Future Targeted Options

(2008) A. Ocana et al.   CLINICAL CANCER RESEARCH

Gefitinib Radiosensitizes Non-Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

(2008) T. Tanaka et al.   CLINICAL CANCER RESEARCH

Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma

(2008) P. Koppikar et al.   CLINICAL CANCER RESEARCH

Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance

(2008) Ton van Agthoven et al.   JOURNAL OF CLINICAL ONCOLOGY

WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity

(2008) Andrew Xiao et al.   NATURE

A quantitative analysis of kinase inhibitor selectivity

(2008) Mazen W Karaman et al.   NATURE BIOTECHNOLOGY

Caspase-independent cell death: leaving the set without the final cut

(2008) S W G Tait et al.   ONCOGENE

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

(2008) C Garcia-Echeverria et al.   ONCOGENE